Acute Hypotension

1. Disease Information

1.1 Overview (what is the disease?)

Acute hypotension is an abrupt fall in arterial blood pressure that may be transient or sustained and can lead to inadequate organ perfusion (shock physiology) and downstream organ injury depending on severity and duration. In ICU literature, hypotension definitions are highly heterogeneous—one recent systematic review identified 140 distinct definitions—but MAP <65 mmHg is the most frequently used ICU threshold. (schuurmans2024hypotensionduringintensive pages 1-2)

A practical clinical framing used in bedside shock literature is that shock is circulatory failure causing insufficient oxygen delivery to meet tissue demands, with a “pre-shock” phase in which tissue hypoperfusion may occur even before hypotension develops. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

1.2 Key identifiers and coding systems

• ICD-10: Hypotension is coded under the I95. family (subcodes vary by context). In US mortality administrative data, hypotension may be captured as I95.9 (hypotension, unspecified)*, but authors caution this code may represent a terminal physiologic state rather than a primary disease entity. (asghar2026hypotensionunspecifieduncharted pages 1-3)
• MeSH / OMIM / Orphanet / MONDO: Not established from the retrieved sources; acute hypotension is commonly treated as a sign/syndrome rather than a monogenic disorder. (schuurmans2024hypotensionduringintensive pages 1-2, oliveira2024uncomplicatedcirculatoryshock pages 1-2)

1.3 Synonyms / alternative names

Common alternative labels in the retrieved literature include: * “Hypotension” during ICU stay (schuurmans2024hypotensionduringintensive pages 1-2) * “Circulatory shock” (syndrome-level framing) (oliveira2024uncomplicatedcirculatoryshock pages 1-2) * “Intraoperative hypotension (IOH)” and “post-induction hypotension (PIH)” (perioperative) (maleczek2024definitionofclinically pages 7-8, ripollesmelchor2023hypotensionpredictionindex pages 2-3) * “Post-intubation hypotension (PIH)” (airway/procedural) (pan2024recentadvancesin pages 1-2, anand2024impactofresuscitation pages 1-7)

1.4 Source type

Most information here is derived from aggregated disease-level resources (systematic reviews, narrative reviews, clinical cohorts, and trials), not from single-patient case series. (schuurmans2024hypotensionduringintensive pages 1-2, oliveira2024uncomplicatedcirculatoryshock pages 1-2, mohamed2024theeffectof pages 1-2)

2. Etiology

Acute hypotension is best handled as a final common hemodynamic phenotype with multiple etiologies.

2.1 Primary causal factors (clinical categories)

A bedside shock taxonomy remains in common use: * Cardiogenic: pump failure * Hypovolemic (including hemorrhagic): inadequate circulating volume * Obstructive: mechanical impediment to inflow/outflow * Vasoplegic/distributive: failure of peripheral vascular tone (includes sepsis and anaphylaxis)
This classification is explicitly described in a 2024 shock narrative review. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

2.2 Major risk factors (examples with evidence)

Procedure-related hypotension (peri-intubation): * In trauma patients undergoing prehospital emergency anesthesia, PIH (new SBP <90 mmHg within 10 min, or relative drop if baseline <90) occurred in 21.8% (218/998). Risk associations included older age (>55 years), pre-intubation tachycardia, multisystem injury, and pre-arrival crystalloid. (anand2024impactofresuscitation pages 1-7) * In isolated TBI requiring emergent intubation, PIH defined as SBP fall ≥20% or SBP ≤80 mmHg or MAP ≤60 mmHg occurred in 62% (304/490). (anand2024impactofresuscitation pages 1-7)

Anaphylaxis severity / treatment-response modifiers: A 2024 overview of refractory anaphylaxis guidelines notes that genetic factors may modulate severity/response, including “deficiency in platelet activating factor-acetyl hydrolase” and “hereditary alpha-tryptasaemia,” as well as mastocytosis. (pauw2024frequencyofcardiotoxicity pages 1-2)

Sepsis-related hypotension / shock: Surviving Sepsis Campaign (SSC) Research Priorities 2023 identify key gaps directly tied to acute hypotension in sepsis, including: “what is the best vasopressor approach for treating the different phases of septic shock?” and how genetics/epigenetics influence sepsis development and treatment response. (backer2024survivingsepsiscampaign pages 1-2, backer2024survivingsepsiscampaign pages 18-20)

2.3 Protective factors

The retrieved corpus did not provide robust, quantified protective factors specific to “acute hypotension” as a syndrome. Some peri-intubation and hemorrhagic shock studies suggest modifiable protective interventions (e.g., pre-intubation vasopressors/HTS; early low-dose norepinephrine), which function as preventive strategies for iatrogenic or progression-related hypotension rather than intrinsic protective factors. (anand2024impactofresuscitation pages 1-7, mohamed2024theeffectof pages 1-2)

2.4 Gene–environment interactions

Direct gene–environment interaction evidence for acute hypotension was not retrieved. SSC priorities emphasize that genetics/epigenetics likely influence sepsis susceptibility, severity, and treatment response, indicating a major open research area relevant to hypotension in sepsis. (backer2024survivingsepsiscampaign pages 18-20)

3. Phenotypes (clinical features)

3.1 Core clinical phenotype

In shock physiology, skin and perfusion findings are emphasized: cold/pale/moist/mottled skin and prolonged capillary refill time (CRT), with possible hyperlactatemia even before hypotension (pre-shock). (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

3.2 Quantitative hypotension thresholds used in recent literature

Because thresholds are context-dependent, clinical research commonly operationalizes hypotension using SBP and/or MAP cutoffs and sometimes relative drops.

• ICU (general): MAP <65 mmHg is “most frequently used” despite heterogeneity. (schuurmans2024hypotensionduringintensive pages 1-2)
• Sepsis trials/targets: MAP <65 mmHg used for inclusion and MAP ≥65 mmHg used as a resuscitation target; shock control definitions often include perfusion markers (urine output and lactate change). (antonucci2024hemodynamicsupportin pages 4-5)
• Post-intubation hypotension: definitions include SBP <90 mmHg and/or MAP <65 mmHg and/or >20% drop from baseline; incidence reported as 19–52% across studies. (pan2024recentadvancesin pages 1-2)
• TBI peri-intubation (2024 cohort): PIH defined as SBP decrease ≥20% or SBP ≤80 mmHg or MAP ≤60 mmHg. (anand2024impactofresuscitation pages 1-7)

A consolidated table of thresholds and outcome links is provided below.

Table: This table compares commonly used acute hypotension definitions across ICU, sepsis, perioperative, peri-intubation, and postoperative settings, alongside key quantitative outcomes from the gathered evidence. It is useful for harmonizing thresholds and linking them to clinically important morbidity and mortality data.

3.3 Suggested phenotype ontology mappings (HPO suggestions)

Direct ontology IDs were not present in the retrieved sources; below are suggestions for knowledge-base normalization: * Hypotension (HPO: Hypotension) * Shock (HPO: Shock) * Decreased capillary refill time (HPO: Abnormality of capillary refill / prolonged CRT) * Oliguria (HPO: Oliguria) * Hyperlactatemia (HPO: Lactic acidosis / Increased blood lactate)

4. Genetic / Molecular Information

4.1 Causal genes

Acute hypotension is not typically monogenic. No causal-gene evidence for “acute hypotension” as a standalone entity was retrieved.

4.2 Genetic modifiers and epigenetics (most relevant in sepsis)

SSC 2023 Research Priorities explicitly identify genetics and epigenetics as an underexplored but important domain in sepsis, stating that the link between genetic factors and “susceptibility, severity and evolution of sepsis” is not fully understood. (backer2024survivingsepsiscampaign pages 18-20)

For anaphylaxis-related hypotension severity/response, guideline overviews cite candidate genetic factors such as platelet-activating-factor acetylhydrolase deficiency and hereditary alpha-tryptasemia as potential modifiers. (pauw2024frequencyofcardiotoxicity pages 1-2)

4.3 Molecular profiling

Not established for “acute hypotension” broadly in the retrieved evidence. For sepsis, the SSC priorities and related reviews frame precision approaches (including biology-driven stratification) as research needs rather than routine care. (backer2024survivingsepsiscampaign pages 1-2)

5. Environmental Information

Environmental precipitants of acute hypotension are largely contextual exposures (e.g., infection leading to sepsis, allergens leading to anaphylaxis, trauma/hemorrhage, anesthetic/induction drugs). The retrieved sources emphasize the need for rapid bedside differentiation rather than isolating specific toxins. (oliveira2024uncomplicatedcirculatoryshock pages 1-2, pan2024recentadvancesin pages 1-2)

6. Mechanism / Pathophysiology

6.1 Causal chain (syndrome-level)

A general mechanistic chain is: trigger (infection/trauma/allergen/procedure) → hemodynamic disturbance (pump failure, volume loss, vasodilation/vasoplegia, obstruction) → tissue hypoperfusion and cellular hypoxia → organ dysfunction and multi-organ failure if not reversed. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

6.2 Sepsis-associated mechanisms (selected)

A 2024 sepsis hemodynamics review notes that sepsis-induced organ injury can result from microvascular dysfunction, immune and autonomic dysfunction, apoptosis, mitochondrial damage, and coagulation disorders, framing hypotension as one component of a broader pathobiology. (antonucci2024hemodynamicsupportin pages 1-2)

6.3 Intubation-related hypotension mechanisms

A 2024 PIH review attributes mechanisms to sympathetic suppression, vagal activation, effects of positive-pressure ventilation on venous return/cardiac output, and direct hemodynamic effects of induction drugs, while emphasizing inconsistent diagnostic criteria across studies. (pan2024recentadvancesin pages 1-2)

6.4 Suggested GO / CL / UBERON mappings (high-level suggestions)

Because explicit pathway annotations were not provided in the retrieved corpus, the following are high-level suggestions consistent with shock biology: * GO biological processes: regulation of blood pressure; response to hypoxia; inflammatory response; coagulation; regulation of vascular tone. * CL cell types: vascular endothelial cell; vascular smooth muscle cell; monocyte/macrophage; cardiomyocyte. * UBERON organs/structures: systemic arterial circulation; heart; kidney; brain; microvasculature.

7. Anatomical Structures Affected

Acute hypotension/shock is systemic but clinically important organ targets include: * Brain (risk of hypoperfusion, especially in TBI where hypotension can exacerbate injury) (anand2024impactofresuscitation pages 1-7) * Kidney (hypotension exposure associated with AKI in many observational studies; postoperative ICU hypotension at MAP ≤55 mmHg associated with AKI stage II/III) (smischney2020postoperativehypotensionin pages 1-2, schuurmans2024hypotensionduringintensive pages 1-2) * Heart (major adverse cardiac/cerebrovascular events associated with postoperative ICU hypotension) (smischney2020postoperativehypotensionin pages 1-2)

8. Temporal Development

Acute hypotension typically has acute onset (minutes–hours) and may evolve through shock phases: * Pre-shock (compensated): hypoperfusion may precede hypotension * Shock phase: hypotension becomes manifest * Organ injury phase: prolonged hypoperfusion causes organ damage/failure
This phase framing is explicitly described in the 2024 shock narrative review. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

9. Inheritance and Population

Because acute hypotension is not a single inherited disorder, classic inheritance patterns are not applicable.

Epidemiology is cause- and setting-dependent; however, peri-intubation hypotension incidence estimates and ICU associations are available: * PIH incidence 19–52% across studies (review). (pan2024recentadvancesin pages 1-2) * PIH incidence 62% in isolated TBI cohort (2019–2022). (anand2024impactofresuscitation pages 1-7)

Administrative mortality analyses based on I95.9 exist but may be difficult to interpret as disease burden due to coding non-specificity. (asghar2026hypotensionunspecifieduncharted pages 1-3)

10. Diagnostics

10.1 Clinical assessment and bedside testing

A shock review recommends joint analysis of clinical data and routine tests to infer cause; point-of-care ultrasonography and echocardiography are described as “the most valuable non-invasive diagnostic tools.” (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

Common perfusion/organ markers used in shock resuscitation frameworks include: * Lactate (e.g., rising or >2 mM in one sepsis hemodynamic summary table) (antonucci2024hemodynamicsupportin pages 4-5) * Urine output (e.g., >0.5 mL/kg/h targets used in shock control endpoints) (antonucci2024hemodynamicsupportin pages 4-5) * Capillary refill time (e.g., >3 s referenced) (antonucci2024hemodynamicsupportin pages 4-5)

10.2 Dynamic assessment of fluid responsiveness (recent practical synthesis)

In shock management, dynamic tests are emphasized to avoid indiscriminate fluids: * Passive leg raising (PLR) described as equivalent to ~300 mL fluid challenge (oliveira2024uncomplicatedcirculatoryshock pages 6-7) * Reported diagnostic performance in one summary: PLR increase in CO ≥11% sensitivity 88%, specificity 92%; end-expiratory occlusion test cardiac index increase ≥5% sensitivity 91%, specificity 100% (oliveira2024uncomplicatedcirculatoryshock pages 6-7)

10.3 Differential diagnosis (etiologic workup)

Core differentials align with cardiogenic/hypovolemic/obstructive/vasoplegic shock categories and should be guided by history/exam plus ECG, radiography, labs (including troponin, BNP, D-dimer, gases, lactate), and ultrasound/echo. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

10.4 Coding-based ascertainment caveat

Claims databases may lack physiologic BP measurements and therefore identify hypotension using diagnosis codes, limiting severity phenotyping and mechanistic inference. (holtz2022economicoutcomesand pages 7-8)

11. Outcomes / Prognosis

11.1 ICU outcomes (2024 synthesis)

A 2024 systematic review/meta-analysis of ICU hypotension (122 studies; 176,329 patients) found hypotension associated with mortality (meta-analysis OR 1.45, 95% CI 1.12–1.88). (schuurmans2024hypotensionduringintensive pages 1-2)

11.2 Postoperative ICU outcomes (reference thresholds)

In a large multi-center retrospective ICU postoperative cohort (non-cardiac surgery), postoperative hypotension at MAP ≤65 and ≤55 mmHg was associated with higher 30- and 90-day mortality and MACCE; MAP ≤55 was also associated with AKI stage II/III. (smischney2020postoperativehypotensionin pages 1-2)

11.3 Anaphylaxis treatment safety outcome statistic (2024)

Among 338 adult ED anaphylaxis patients receiving IM epinephrine, cardiotoxicity (composite definition) occurred in 4.7% (16/338). (pauw2024frequencyofcardiotoxicity pages 1-2)

12. Treatment

Treatment is cause-directed but shares common hemodynamic stabilization principles.

12.1 Immediate stabilization / implementation (shock physiology)

Bedside shock care emphasizes rapid restoration of venous return and cardiac output and avoidance of delay in cause identification; POCUS/echo is central. (oliveira2024uncomplicatedcirculatoryshock pages 1-2)

12.2 Sepsis-associated acute hypotension: early vasopressors and MAP targets (2024 review synthesis)

A 2024 sepsis hemodynamics review describes an early resuscitation approach with MAP target ~65 mmHg and norepinephrine as first-line vasopressor, noting early vasopressors may be considered (including peripheral infusion in some contexts). (antonucci2024hemodynamicsupportin media 3450bcbc)

In the ED sepsis trial summarized in that review (CENSER), early norepinephrine increased shock control by 6 hours (76.1% vs 48.4%) and reduced cardiogenic pulmonary edema and new arrhythmia. (antonucci2024hemodynamicsupportin pages 4-5)

12.3 Hemorrhagic shock (2024 RCT)

A 2024 randomized trial in severely traumatized hemorrhagic shock patients (inclusion MAP 65–75 mmHg) reported that early low-dose norepinephrine plus fluids reduced 24-hour mortality (3% vs 13%) and in-hospital mortality (9% vs 21%), with lower fluid requirement and improved lactate/creatinine trajectories. (mohamed2024theeffectof pages 1-2)

12.4 Peri-intubation hypotension prevention/mitigation (2024 TBI cohort)

In isolated TBI intubations, pre-intubation vasopressors and hypertonic saline were associated with reduced odds of PIH. (anand2024impactofresuscitation pages 1-7)

12.5 Anaphylaxis (guideline-aligned key points and refractory cases)

Anaphylaxis is characterized by systemic reactions that may include hypotension, and epinephrine is the core acute treatment; the 2023 practice parameter update is referenced as emphasizing that meeting diagnostic criteria is not required to treat severe reactions and that epinephrine is first-line (reviewed in 2024). (shaker2024anaphylaxisdefinitionand pages 1-2)

For refractory anaphylaxis, a 2024 guideline overview notes recommendations for timely aggressive fluids and IV adrenaline; the preferred second-line vasopressor is uncertain, and IV glucagon is commonly recommended for patients on beta-blockers despite limited evidence; rescue therapies include methylene blue or extracorporeal life support. (pauw2024frequencyofcardiotoxicity pages 1-2)

12.6 MAXO treatment ontology suggestions (high-level)

• Vasopressor therapy (e.g., norepinephrine infusion)
• Intravenous fluid therapy (balanced crystalloids)
• Point-of-care ultrasonography
• Endotracheal intubation with hemodynamic optimization/prevention of peri-intubation hypotension
• Epinephrine administration (intramuscular; intravenous infusion for refractory anaphylaxis)

13. Prevention

Prevention is primarily secondary/tertiary: preventing progression to organ injury by avoiding delays and iatrogenic hypotension.

13.1 Predictive/proactive hemodynamic management (perioperative)

A 2023 perioperative review describes the shift from reactive to predictive hemodynamic management (e.g., algorithms with MAP targets and vasopressors to maintain perfusion), with emphasis that deeper hypotension exposures (e.g., MAP <55 mmHg) are linked to adverse outcomes. (ripollesmelchor2023hypotensionpredictionindex pages 2-3)

14. Other Species / Natural Disease

No naturally occurring comparative-animal epidemiology for “acute hypotension” was retrieved. The most relevant cross-species content in the corpus pertains to sepsis research, where translation from animal models to humans is highlighted as a major limitation and research target. (backer2024survivingsepsiscampaign pages 18-20)

15. Model Organisms

SSC Research Priorities explicitly call to improve animal models so they better resemble human sepsis and to align outcome variables between animals and humans; this is directly relevant to modeling hypotension/shock mechanisms in sepsis. (backer2024survivingsepsiscampaign pages 1-2, backer2024survivingsepsiscampaign pages 18-20)

Recent developments and expert analysis (2023–2024 highlights)

1. Harmonization remains unresolved: ICU hypotension remains defined in many ways (140 definitions), yet MAP <65 mmHg is still the dominant operational threshold; observational associations are consistent and severity-dependent. (schuurmans2024hypotensionduringintensive pages 1-2)
2. Earlier vasopressor strategies are increasingly supported in sepsis resuscitation syntheses; early norepinephrine improves short-term shock control and may reduce cardiopulmonary complications, aligning with algorithmic care maps. (antonucci2024hemodynamicsupportin pages 4-5, antonucci2024hemodynamicsupportin media 3450bcbc)
3. Cause- and phase-specific BP targets are emphasized as research priorities; SSC Research Priorities 2023 explicitly target improved vasopressor strategy definition across septic shock phases and deeper mechanistic understanding (including genetics/epigenetics). (backer2024survivingsepsiscampaign pages 1-2, backer2024survivingsepsiscampaign pages 18-20)
4. Safety quantification in anaphylaxis care: recent ED data quantify IM epinephrine cardiotoxicity at ~5%, contextualizing clinician hesitancy against life-saving benefit. (pauw2024frequencyofcardiotoxicity pages 1-2)

Visual evidence (recent algorithm)

A 2024 sepsis hemodynamics review figure depicts early resuscitation/optimization phases and a MAP 65 mmHg target with norepinephrine as first-line vasopressor. (antonucci2024hemodynamicsupportin media 3450bcbc)

Limitations of this report (evidence gaps)

• MONDO/MeSH/OMIM identifiers were not recoverable from the retrieved papers; direct ontology database lookup is required. (schuurmans2024hypotensionduringintensive pages 1-2, oliveira2024uncomplicatedcirculatoryshock pages 1-2)
• Many key claims about acute hypotension are intrinsically setting- and etiology-dependent; the strongest quantitative evidence is in ICU/sepsis/perioperative/peri-intubation contexts rather than a unified “acute hypotension” cohort. (schuurmans2024hypotensionduringintensive pages 1-2, pan2024recentadvancesin pages 1-2)

Key cited sources (with publication dates and URLs)

• Schuurmans J. et al. Hypotension during intensive care stay and mortality and morbidity. Intensive Care Medicine. Jan 2024. https://doi.org/10.1007/s00134-023-07304-4 (schuurmans2024hypotensionduringintensive pages 1-2)
• Antonucci E. et al. Hemodynamic Support in Sepsis. Anesthesiology. May 2024. https://doi.org/10.1097/ALN.0000000000004958 (antonucci2024hemodynamicsupportin pages 1-2)
• de Oliveira M.D.C. et al. Uncomplicated circulatory shock: a narrative review. einstein (São Paulo). Oct 2024. https://doi.org/10.31744/einstein_journal/2024rw0775 (oliveira2024uncomplicatedcirculatoryshock pages 1-2)
• Anand T. et al. Impact of resuscitation adjuncts on postintubation hypotension in isolated TBI. J Trauma Acute Care Surg. Mar 2024. https://doi.org/10.1097/TA.0000000000004306 (anand2024impactofresuscitation pages 1-7)
• Mohamed R.M. et al. Low-dose norepinephrine before hypotensive resuscitation in hemorrhagic shock (RCT). Anaesthesia, Pain & Intensive Care. Oct 2024. https://doi.org/10.35975/apic.v28i5.2560 (mohamed2024theeffectof pages 1-2)
• Pauw E.K. et al. Cardiotoxicity after IM epinephrine for anaphylaxis. JACEP Open. Feb 2024 (Accepted Dec 13, 2023). https://doi.org/10.1002/emp2.13095 (pauw2024frequencyofcardiotoxicity pages 1-2)
• De Backer D. et al. Surviving Sepsis Campaign Research Priorities 2023. Critical Care Medicine. Jan 2024. https://doi.org/10.1097/CCM.0000000000006135 (backer2024survivingsepsiscampaign pages 1-2)

References

1. (schuurmans2024hypotensionduringintensive pages 1-2): Jaap Schuurmans, Benthe T. B. van Rossem, Santino R. Rellum, Johan T. M. Tol, Vincent C. Kurucz, Niels van Mourik, Ward H. van der Ven, Denise P. Veelo, Jimmy Schenk, and Alexander P. J. Vlaar. Hypotension during intensive care stay and mortality and morbidity: a systematic review and meta-analysis. Intensive Care Medicine, 50:516-525, Jan 2024. URL: https://doi.org/10.1007/s00134-023-07304-4, doi:10.1007/s00134-023-07304-4. This article has 37 citations and is from a highest quality peer-reviewed journal.

2. (oliveira2024uncomplicatedcirculatoryshock pages 1-2): Mauro Dirlando Conte de Oliveira, Oscar Fernando Pavão dos Santos, Giancarlo Colombo, Thiago Domingos Corrêa, and Miguel Cendoroglo. Uncomplicated circulatory shock: a narrative review. Einstein, Oct 2024. URL: https://doi.org/10.31744/einstein_journal/2024rw0775, doi:10.31744/einstein_journal/2024rw0775. This article has 0 citations.

3. (asghar2026hypotensionunspecifieduncharted pages 1-3): Palwasha Asghar, Muhammad Bilal Masood, Sahla Waqas, Wajeeha Iftikhar Shah, Fatima Fazal, and Raghabendra Kumar Mahato. Hypotension, unspecified: uncharted mortality trends and disparities in the united states, a cdc wonder analysis (1999-2025). Unknown journal, Apr 2026. URL: https://doi.org/10.21203/rs.3.rs-9541628/v1, doi:10.21203/rs.3.rs-9541628/v1.

4. (maleczek2024definitionofclinically pages 7-8): Mathias Maleczek, Daniel Laxar, Angelika Geroldinger, Andreas Gleiss, Paul Lichtenegger, and Oliver Kimberger. Definition of clinically relevant intraoperative hypotension: a data-driven approach. PLOS ONE, 19:e0312966, Nov 2024. URL: https://doi.org/10.1371/journal.pone.0312966, doi:10.1371/journal.pone.0312966. This article has 7 citations and is from a peer-reviewed journal.

5. (ripollesmelchor2023hypotensionpredictionindex pages 2-3): Javier Ripollés-Melchor, Alicia Ruiz-Escobar, Paula Fernández-Valdes-Bango, Juan V. Lorente, Ignacio Jiménez-López, Alfredo Abad-Gurumeta, Laura Carrasco-Sánchez, and M. Ignacio Monge-García. Hypotension prediction index: from reactive to predictive hemodynamic management, the key to maintaining hemodynamic stability. Frontiers in Anesthesiology, Apr 2023. URL: https://doi.org/10.3389/fanes.2023.1138175, doi:10.3389/fanes.2023.1138175. This article has 28 citations.

6. (pan2024recentadvancesin pages 1-2): E. Pan and Yao Chen. Recent advances in understanding the pathophysiology and risk stratification of post-intubation hypotension. Asploro Journal of Biomedical and Clinical Case Reports, 8:20-29, Dec 2024. URL: https://doi.org/10.36502/2024/asjbccr.6384, doi:10.36502/2024/asjbccr.6384. This article has 0 citations.

7. (anand2024impactofresuscitation pages 1-7): Tanya Anand, Omar Hejazi, Madolyn Conant, Dylan Joule, Megan Lundy, Christina Colosimo, Audrey Spencer, Adam Nelson, Lou Magnotti, and Bellal Joseph. Impact of resuscitation adjuncts on postintubation hypotension in patients with isolated traumatic brain injury. Journal of Trauma and Acute Care Surgery, 97:112-118, Mar 2024. URL: https://doi.org/10.1097/ta.0000000000004306, doi:10.1097/ta.0000000000004306. This article has 3 citations and is from a peer-reviewed journal.

8. (mohamed2024theeffectof pages 1-2): Rabab Mohamed Mohamed, Atia Gad Anwar, and Ahmed Aboelhasan Eid. The effect of using low dose norepinephrine before hypotensive resuscitation in hemorrhagic shock; a randomized controlled trial. Anaesthesia, Pain & Intensive Care, 28:914-921, Oct 2024. URL: https://doi.org/10.35975/apic.v28i5.2560, doi:10.35975/apic.v28i5.2560. This article has 2 citations.

9. (pauw2024frequencyofcardiotoxicity pages 1-2): Emily K. Pauw, William B. Stubblefield, Jesse O. Wrenn, Sarah K. Brown, Millie S. Cosse, Zoe S. Curry, Terence P. Darcy, Tia'Asia E. James, Paige E. Koetter, Caitlin E. Nicholson, Frank N. Parisi, Laura G. Shepherd, Savannah L. Soppet, Michael D. Stocker, Bernard M. Walston, Wesley H. Self, Jin H. Han, and Michael J. Ward. Frequency of cardiotoxicity following intramuscular administration of epinephrine in emergency department patients with anaphylaxis. JACEP Open, 5:e13095, Feb 2024. URL: https://doi.org/10.1002/emp2.13095, doi:10.1002/emp2.13095. This article has 10 citations.

10. (backer2024survivingsepsiscampaign pages 1-2): Daniel De Backer, Clifford S. Deutschman, Judith Hellman, Sheila Nainan Myatra, Marlies Ostermann, Hallie C. Prescott, Daniel Talmor, Massimo Antonelli, Luciano Cesar Pontes Azevedo, Seth R. Bauer, Niranjan Kissoon, Ignacio-Martin Loeches, Mark Nunnally, Pierre Tissieres, Antoine Vieillard-Baron, and Craig M. Coopersmith. Surviving sepsis campaign research priorities 2023. Critical Care Medicine, 52:268-296, Jan 2024. URL: https://doi.org/10.1097/ccm.0000000000006135, doi:10.1097/ccm.0000000000006135. This article has 162 citations and is from a domain leading peer-reviewed journal.

11. (backer2024survivingsepsiscampaign pages 18-20): Daniel De Backer, Clifford S. Deutschman, Judith Hellman, Sheila Nainan Myatra, Marlies Ostermann, Hallie C. Prescott, Daniel Talmor, Massimo Antonelli, Luciano Cesar Pontes Azevedo, Seth R. Bauer, Niranjan Kissoon, Ignacio-Martin Loeches, Mark Nunnally, Pierre Tissieres, Antoine Vieillard-Baron, and Craig M. Coopersmith. Surviving sepsis campaign research priorities 2023. Critical Care Medicine, 52:268-296, Jan 2024. URL: https://doi.org/10.1097/ccm.0000000000006135, doi:10.1097/ccm.0000000000006135. This article has 162 citations and is from a domain leading peer-reviewed journal.

12. (antonucci2024hemodynamicsupportin pages 4-5): Edoardo Antonucci, Bruno Garcia, and Matthieu Legrand. Hemodynamic support in sepsis. Anesthesiology, 140:1205-1220, May 2024. URL: https://doi.org/10.1097/aln.0000000000004958, doi:10.1097/aln.0000000000004958. This article has 5 citations and is from a domain leading peer-reviewed journal.

13. (smischney2020postoperativehypotensionin pages 1-2): Nathan J. Smischney, Andrew D. Shaw, Wolf H. Stapelfeldt, Isabel J. Boero, Qinyu Chen, Mitali Stevens, and Ashish K. Khanna. Postoperative hypotension in patients discharged to the intensive care unit after non-cardiac surgery is associated with adverse clinical outcomes. Critical Care, Dec 2020. URL: https://doi.org/10.1186/s13054-020-03412-5, doi:10.1186/s13054-020-03412-5. This article has 75 citations and is from a highest quality peer-reviewed journal.

14. (antonucci2024hemodynamicsupportin pages 1-2): Edoardo Antonucci, Bruno Garcia, and Matthieu Legrand. Hemodynamic support in sepsis. Anesthesiology, 140:1205-1220, May 2024. URL: https://doi.org/10.1097/aln.0000000000004958, doi:10.1097/aln.0000000000004958. This article has 5 citations and is from a domain leading peer-reviewed journal.

15. (oliveira2024uncomplicatedcirculatoryshock pages 6-7): Mauro Dirlando Conte de Oliveira, Oscar Fernando Pavão dos Santos, Giancarlo Colombo, Thiago Domingos Corrêa, and Miguel Cendoroglo. Uncomplicated circulatory shock: a narrative review. Einstein, Oct 2024. URL: https://doi.org/10.31744/einstein_journal/2024rw0775, doi:10.31744/einstein_journal/2024rw0775. This article has 0 citations.

16. (holtz2022economicoutcomesand pages 7-8): Margaret Holtz, Nick Liao, Jennifer H. Lin, and Carl V. Asche. Economic outcomes and incidence of postsurgical hypotension with liposomal bupivacaine vs epidural analgesia in abdominal surgeries. Journal of Health Economics and Outcomes Research, Sep 2022. URL: https://doi.org/10.36469/001c.37739, doi:10.36469/001c.37739. This article has 5 citations.

17. (antonucci2024hemodynamicsupportin media 3450bcbc): Edoardo Antonucci, Bruno Garcia, and Matthieu Legrand. Hemodynamic support in sepsis. Anesthesiology, 140:1205-1220, May 2024. URL: https://doi.org/10.1097/aln.0000000000004958, doi:10.1097/aln.0000000000004958. This article has 5 citations and is from a domain leading peer-reviewed journal.

18. (shaker2024anaphylaxisdefinitionand pages 1-2): Marcus S. Shaker. Anaphylaxis: definition and criteria. Journal of Food Allergy, 6:26-31, Jul 2024. URL: https://doi.org/10.2500/jfa.2024.6.240002, doi:10.2500/jfa.2024.6.240002. This article has 8 citations.